Etanercept Biosimilar - Research Grade
Product Sizes
1 mg
ICH4022-1MG
5 mg
ICH4022-5MG
10 mg
ICH4022-10MG
25 mg
ICH4022-25MG
50 mg
ICH4022-50MG
100 mg
ICH4022-100MG
200 mg
ICH4022-200MG
500 mg
ICH4022-500MG
1 g
ICH4022-1G
About this Product
- SKU:
- ICH4022
- Additional Names:
- Tumor necrosis factor
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1-5 mg/ml
- Extra Details:
- Etanercept biosimilar is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept biosimilar is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids and has an apparent molecular weight of approximately 150 kilodaltons.
- Formulation:
- Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
- Host:
- Human
- Immunogen:
- TNF alpha
- Purity:
- >95%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human TNF. This non-therapeutic fusion-protein uses the same sequence as the therapeutic Etanercept.
- Storage Conditions:
- 2-8[o]C Aliquot. Avoid freeze/thaw cycles., -70[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/etanercept-biosimilar-research-grade-ich4022/
